Yoshio Anazawa
About Yoshio Anazawa
Yoshio Anazawa is the Director of Oncology Medical GU and Melanoma at Bristol-Myers Squibb, with over 15 years of experience in oncology drug discovery and development.
Current Role at Bristol-Myers Squibb
Yoshio Anazawa currently serves as the Director of Oncology Medical GU and Melanoma for Japan Medical and Development at Bristol-Myers Squibb. In this role, he oversees the direction and strategic initiatives of oncology treatments, specifically targeting genitourinary (GU) cancers and melanoma. His responsibilities likely include managing both clinical and developmental aspects of these oncological areas, ensuring alignment with the company's broader medical and business goals.
Previous Role at Bristol-Myers Squibb
Before becoming the Director at Bristol-Myers Squibb, Yoshio Anazawa worked as the Medical Strategy Lead for Immuno-Oncology within Japan Medical and Development. During his tenure from 2015 to 2016, he was based in New York, New York, United States. His role involved formulating strategies for immuno-oncology treatments, contributing to the company's development and deployment of innovative cancer therapies.
Experience at Takeda Pharmaceuticals
Yoshio Anazawa has an extensive background with Takeda Pharmaceuticals, holding several key positions. From 2014 to 2015, he was the Manager of the Corporate Strategy Department, where he directed strategic initiatives within the company. From 2013 to 2014, he served as Manager of the Strategic Planning Group within the Pharmaceutical Research Division. Additionally, he was the Project Leader and Principal Scientist in the Oncology Drug Discovery Unit from 2011 to 2013. Earlier in his career, from 2005 to 2011, he was a Principal Scientist also in the Oncology Drug Discovery Unit, contributing to significant research and development projects.
Role at UCLA
In 2011, Yoshio Anazawa worked as a Visiting Senior Researcher at UCLA for five months. This role represented an important international collaboration and added valuable experience to his scientific and research acumen, particularly within the field of oncology.
Overall Experience in Oncology
Yoshio Anazawa brings over 15 years of experience in oncology drug discovery and development. His work encompasses both corporate strategy and hands-on scientific research across multiple prestigious institutions. He has played crucial roles in strategic planning and the development of innovative cancer treatment strategies. His international experience includes positions in the United States and Japan, highlighting his global expertise in the pharmaceutical industry.